MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033…
MaaT PharmaJuly 2, 2024
MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer Lyon, France, June 24th…
MaaT PharmaJune 24, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJune 10, 2024
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting Lyon, France,…
MaaT PharmaMay 29, 2024
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaMay 15, 2024
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaMay 14, 2024
MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2024 Positive efficacy…
MaaT PharmaMay 7, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaMay 6, 2024
MaaT Pharma to Hold Annual General Meeting on May 28, 2024 Lyon, France, April 22nd…
MaaT PharmaApril 22, 2024
